Literature DB >> 20196775

Epileptic phenotypes in children with respiratory chain disorders.

Sandra El Sabbagh1, Anne-Sophie Lebre, Nadia Bahi-Buisson, Pascale Delonlay, Christine Soufflet, Nathalie Boddaert, Marlène Rio, Agnès Rötig, Olivier Dulac, Arnold Munnich, Isabelle Desguerre.   

Abstract

PURPOSE: Epilepsy is a commonly reported but rarely described clinical hallmark of mitochondrial respiratory chain defects (RCDs) with encephalopathy.
METHODS: From 1990-2006 we collected data about 56 children with RCD (single, n = 24 or multiple, n = 20 mitochondrial complex deficiencies; mtDNA mutation, n = 11; mtDNA depletion n = 10 of 21; and nuclear gene mutation n = 11). Epileptic features were reviewed retrospectively.
RESULTS: First seizures were frequently (47 patients, 82.5%) preceded by failure to thrive, psychomotor delay, ataxia, or multisystemic dysfunction. Sixty percent of the patients had several seizure types. Six age-related epilepsy phenotypes could be identified: status epilepticus complicating neonatal multivisceral deficiency (2 patients), neonatal myoclonic encephalopathy (3 patients), infantile spasms (8 patients), refractory or recurrent status epilepticus (21 patients), epilepsia partialis continua (4 patients), and myoclonic epilepsy (18 patients). Except for infantile spasms, epilepsy was difficult to control in most patients (95%). Valproate was administered to 25 patients, one of whom developed acute liver failure 6 days later. Twenty-two patients (45%) died, half of them within 9 months from the onset of epilepsy. DISCUSSION: In RCD, epilepsy is not only difficult to control but its occurrence often indicates a severe turn in the course of the disease. For one-third of the patients, classical biochemical measures failed to reveal any abnormality and RCD could be detected in the liver only.

Entities:  

Mesh:

Year:  2010        PMID: 20196775     DOI: 10.1111/j.1528-1167.2009.02504.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

1.  Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy number.

Authors:  Brenda Luna; Sanjiv Bhatia; Changwon Yoo; Quentin Felty; David I Sandberg; Michael Duchowny; Ziad Khatib; Ian Miller; John Ragheb; Jayakar Prasanna; Deodutta Roy
Journal:  J Mol Neurosci       Date:  2014-07-16       Impact factor: 3.444

2.  Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy.

Authors:  Ortal Barel; May Christine V Malicdan; Bruria Ben-Zeev; Judith Kandel; Hadass Pri-Chen; Joshi Stephen; Inês G Castro; Jeremy Metz; Osama Atawa; Sharon Moshkovitz; Esther Ganelin; Iris Barshack; Sylvie Polak-Charcon; Dvora Nass; Dina Marek-Yagel; Ninette Amariglio; Nechama Shalva; Thierry Vilboux; Carlos Ferreira; Ben Pode-Shakked; Gali Heimer; Chen Hoffmann; Tal Yardeni; Andreea Nissenkorn; Camila Avivi; Eran Eyal; Nitzan Kol; Efrat Glick Saar; Douglas C Wallace; William A Gahl; Gideon Rechavi; Michael Schrader; David M Eckmann; Yair Anikster
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

3.  West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.

Authors:  Ali Abdullah Alfaiz; Verena Müller; Nadia Boutry-Kryza; Dorothée Ville; Nicolas Guex; Julitta de Bellescize; Clotilde Rivier; Audrey Labalme; Vincent des Portes; Patrick Edery; Marianne Till; Ioannis Xenarios; Damien Sanlaville; Johannes M Herrmann; Gaétan Lesca; Alexandre Reymond
Journal:  Eur J Hum Genet       Date:  2015-10-21       Impact factor: 4.246

4.  Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.

Authors:  Konstantina Fragaki; Samira Ait-El-Mkadem; Annabelle Chaussenot; Catherine Gire; Raymond Mengual; Laurent Bonesso; Marie Bénéteau; Jean-Ehrland Ricci; Valérie Desquiret-Dumas; Vincent Procaccio; Agnès Rötig; Véronique Paquis-Flucklinger
Journal:  Eur J Hum Genet       Date:  2012-09-19       Impact factor: 4.246

Review 5.  Acute rhabdomyolysis and inflammation.

Authors:  Yamina Hamel; Asmaa Mamoune; François-Xavier Mauvais; Florence Habarou; Laetitia Lallement; Norma Beatriz Romero; Chris Ottolenghi; Pascale de Lonlay
Journal:  J Inherit Metab Dis       Date:  2015-03-17       Impact factor: 4.982

6.  Treatment of mitochondrial disorders.

Authors:  Sreenivas Avula; Sumit Parikh; Scott Demarest; Jonathan Kurz; Andrea Gropman
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

7.  Mitochondrial epilepsy: a cross-sectional nationwide Italian survey.

Authors:  Chiara Ticci; Federico Sicca; Anna Ardissone; Enrico Bertini; Valerio Carelli; Daria Diodato; Lidia Di Vito; Massimiliano Filosto; Chiara La Morgia; Costanza Lamperti; Diego Martinelli; Isabella Moroni; Olimpia Musumeci; Daniele Orsucci; Elia Pancheri; Lorenzo Peverelli; Guido Primiano; Anna Rubegni; Serenella Servidei; Gabriele Siciliano; Costanza Simoncini; Paola Tonin; Antonio Toscano; Michelangelo Mancuso; Filippo M Santorelli
Journal:  Neurogenetics       Date:  2020-01-03       Impact factor: 2.660

Review 8.  Mitochondrial disease in childhood: nuclear encoded.

Authors:  Amy C Goldstein; Poonam Bhatia; Jodie M Vento
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

9.  Metabolic causes of epileptic encephalopathy.

Authors:  Joe Yuezhou Yu; Phillip L Pearl
Journal:  Epilepsy Res Treat       Date:  2013-05-22

10.  Prospective study of POLG mutations presenting in children with intractable epilepsy: prevalence and clinical features.

Authors:  Johanna Uusimaa; Vasantha Gowda; Anthony McShane; Conrad Smith; Julie Evans; Annie Shrier; Manisha Narasimhan; Anthony O'Rourke; Yusuf Rajabally; Tammy Hedderly; Frances Cowan; Carl Fratter; Joanna Poulton
Journal:  Epilepsia       Date:  2013-02-28       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.